Abstract: An adjustable monitor stand system includes a base, a work platform, and a driving module. The work platform is slidable relative to the base. The driving module is secured to the base and includes a control circuit and a horizontal transmission mechanism. The control circuit can receive a set distance and a set time. The horizontal transmission mechanism is coupled to the work platform and can move the work platform relative to the base in a forward or backward direction based on the set distance and the set time. A method for controlling an adjustable monitor stand system is also disclosed.

Abstract: A method for distinguishing metal objects from a heating cup and a wireless charging device using the method are disclosed. The wireless charging device includes a housing, a power unit, a power transmitter, a current measuring unit, a Q factor measuring unit, a controller, and a temperature detector. The wireless charging device can distinguish metal objects from a heating cup by both current in the power transmitter and the Q factor of the power transmitter. If the heating cup is confirmed, a higher power will be provided to a metal heating layer of the heating cup to heat the liquid in the heating cup; otherwise, a lower power will be provided to charge general electronic devices having a power receiving element.

Abstract: The present application discloses a domino structure system comprising a track, a plurality of rods, a plurality of dominoes, a plurality of stoppers and at least one stand. The track comprises a left rail and a right rail. Each of the rods is coupled to the left rail at rate end and to the right ail at another end. The plurality of dominoes is rotatably coupled to the plurality of rods. The plurality of stoppers is capable of stopping the plurality of dominoes when the plurality of dominoes is perpendicular to the track. The at least one stand comprises a base, a column and a supporter, the column is coupled to the base, the supporter is coupled to the column, wherein the supporter is capable of supporting the track. A domino structure is also disclosed.

Abstract: A backpack includes a pack body, two length-adjustable shoulder straps extended from the pack body for allowing the wearer to wear the pack body at the wearer's back, and a suspension arrangement which includes a resilient unit provided between the pack body and the shoulder straps for absorbing a bounding force of the pack body. Therefore, the resilient unit allows a relative movement of the pack body with respect to each of the shoulder straps but minimizes the relative movement of the pack body by absorbing the bounding force of the pack body. The resilient unit is also arranged for evenly distributing a loading force of the pack body to each of the shoulder straps, such that the resilient unit absorbs the bounding force of the pack body at different directions so as to balance the uneven loading force at the pack body.

Abstract: A backpack includes a pack body, two shoulder straps extended from the pack body for allowing the wearer to wear the pack body at the wearer's back, and a suspension arrangement which includes a resilient unit provided between the pack body and the shoulder straps for absorbing a bounding force of the pack body. Therefore, the resilient unit allows a relative movement of the pack body with respect to each of the shoulder straps but minimizes the relative movement of the pack body by absorbing the bounding force of the pack body. The resilient unit is also arranged for evenly distributing a loading force of the pack body to each of the shoulder straps, such that the resilient unit absorbs the bounding force of the pack body at different directions so as to balance the uneven loading force at the pack body.

Abstract: A backpack includes a pack body, two length-adjustable shoulder straps extended from the pack body for allowing the wearer to wear the pack body at the wearer's back, and a suspension arrangement which includes a resilient unit provided between the pack body and the shoulder straps for absorbing a bounding force of the pack body. Therefore, the resilient unit allows a relative movement of the pack body with respect to each of the shoulder straps but minimizes the relative movement of the pack body by absorbing the bounding force of the pack body. The resilient unit is also arranged for evenly distributing a loading force of the pack body to each of the shoulder straps, such that the resilient unit absorbs the bounding force of the pack body at different directions so as to balance the uneven loading force at the pack body.

Abstract: A backpack includes a pack body, two shoulder straps extended from the pack body for allowing the wearer to wear the pack body at the wearer's back, and a suspension arrangement which includes a resilient unit provided between the pack body and the shoulder straps for absorbing a bounding force of the pack body. Therefore, the resilient unit allows a relative movement of the pack body with respect to each of the shoulder straps but minimizes the relative movement of the pack body by absorbing the bounding force of the pack body. The resilient unit is also arranged for evenly distributing a loading force of the pack body to each of the shoulder straps, such that the resilient unit absorbs the bounding force of the pack body at different directions so as to balance the uneven loading force at the pack body.

Abstract: A long-term implantable arterio-venous shunt device or creation of a fistula is provided that can be used as a therapeutic method for treating chronic obstructive pulmonary disease (COPD). The shunt device is implanted between an artery and a vein, preferably between a peripheral artery and the inferior vena cava. The shunt device and method of creating a fistula increases cardiac output and decreases the systemic vascular resistance and allows a blood flow rate through the shunt device of at least 5 ml/min after the implantation. Based on the effects of the method and device to the respiratory, cardiac and circulatory system, the method and device are beneficial as a therapy to patients with problems or conditions related to these systems.

Abstract: A long-term implantable arterio-venous shunt device or creation of a fistula is provided that can be used as a therapeutic method for treating chronic obstructive pulmonary disease (COPD). The shunt device is implanted between an artery and a vein, preferably between a peripheral artery and the inferior vena cava. The shunt device and method of creating a fistula increases cardiac output and decreases the systemic vascular resistance and allows a blood flow rate through the shunt device of at least 5 ml/min after the implantation. Based on the effects of the method and device to the respiratory, cardiac and circulatory system, the method and device are beneficial as a therapy to patients with problems or conditions related to these systems.

Abstract: A long-term implantable arterio-venous shunt device or creation of a fistula is provided that can be used as a therapeutic method for treating chronic obstructive pulmonary disease (COPD). The shunt device is implanted between an artery and a vein, preferably between a peripheral artery and the inferior vena cava. The shunt device and method of creating a fistula increases cardiac output and decreases the systemic vascular resistance and allows a blood flow rate through the shunt device of at least 5 ml/min after the implantation. Based on the effects of the method and device to the respiratory, cardiac and circulatory system, the method and device are beneficial as a therapy to patients with problems or conditions related to these systems.

Abstract: A long-term implantable arterio-venous shunt device is provided that can be used as a therapeutic method. The shunt device is implanted between an artery and a vein, preferably between the aorta and the inferior vena cava. The shunt device decreases the systemic vascular resistance and allows a blood flow rate through the shunt device of at least 5 ml/min after the implantation. The blood flow rate could be controlled either via an open loop or a closed loop control means. The shunt device could also be a self-adjustable shunt device to self-adjust its structure to control the blood flow rate through its lumen. Based on the effects of the shunt device to the respiratory, cardiac and circulatory system, the implantable shunt device could be beneficial as a therapy to patients with problems or conditions related to these systems.

Abstract: A long-term implantable arterio-venous shunt device or creation of a fistula is provided that can be used as a therapeutic method for treating chronic obstructive pulmonary disease (COPD). The shunt device is implanted between an artery and a vein, preferably between a peripheral artery and the inferior vena cava. The shunt device and method of creating a fistula increases cardiac output and decreases the systemic vascular resistance and allows a blood flow rate through the shunt device of at least 5 ml/min after the implantation. Based on the effects of the method and device to the respiratory, cardiac and circulatory system, the method and device are beneficial as a therapy to patients with problems or conditions related to these systems.

Abstract: A long-term implantable arterio-venous shunt device or creation of a fistula is provided that can be used as a therapeutic method for treating chronic obstructive pulmonary disease (COPD). The shunt device is implanted between an artery and a vein, preferably between a peripheral artery and the inferior vena cava. The shunt device and method of creating a fistula increases cardiac output and decreases the systemic vascular resistance and allows a blood flow rate through the shunt device of at least 5 ml/min after the implantation. Based on the effects of the method and device to the respiratory, cardiac and circulatory system, the method and device are beneficial as a therapy to patients with problems or conditions related to these systems.

Abstract: A long-term implantable arterio-venous shunt device or creation of a fistula is provided that can be used as a therapeutic method for treating chronic obstructive pulmonary disease (COPD). The shunt device is implanted between an artery and a vein, preferably between a peripheral artery and the inferior vena cava. The shunt device and method of creating a fistula increases cardiac output and decreases the systemic vascular resistance and allows a blood flow rate through the shunt device of at least 5 ml/min after the implantation. Based on the effects of the method and device to the respiratory, cardiac and circulatory system, the method and device are beneficial as a therapy to patients with problems or conditions related to these systems.

Abstract: Methods of treating lung proliferative vascular disorders by administering an antiproliferative agent are provided. A preferred antiproliferative agent is a HMG-CoA reductase inhibitor, preferably simvastatin. Vascular occlusion in the pulmonary arteries of the patient is reduced as a result of the treatment through a reduction in neointimal hyperplasia and medial hypertrophy, and the restoration of normal endothelial cell function. The treatment also results in a reversal of right side cardiac hypertrophy. Lung proliferative vascular disorders that can be treated include primary pulmonary hypertension, secondary pulmonary hypertension, Eisenmenger's syndrome, chronic thromboembolic disease, pulmonary fibrosis, obliterative bronchiolitis, or lymphangioleiomyomatosis. Dosages and pharmaceutical formulations are provided.

Abstract: A long-term implantable arterio-venous shunt device is provided that can be used as a therapeutic method. The shunt device is implanted between an artery and a vein, preferably between the aorta and the inferior vena cava. The shunt device decreases the systemic vascular resistance and allows a blood flow rate through the shunt device of at least 5 ml/min after the implantation. The blood flow rate could be controlled either via an open loop or a closed loop control means. The shunt device could also be a self-adjustable shunt device to self-adjust its structure to control the blood flow rate through its lumen. Based on the effects of the shunt device to the respiratory, cardiac and circulatory system, the implantable shunt device could be beneficial as a therapy to patients with problems or conditions related to these systems.